or Try an Advanced Search...

    Technical Analysis for IMMP - Immutep Limited

    Grade Last Price % Change Price Change
    F 1.96 -2.97% -0.06
    IMMP closed down 2.97 percent on Wednesday, November 20, 2024, on 67 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical IMMP trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Calm After Storm Range Contraction -2.97%
    NR7 Range Contraction -2.97%
    BB Squeeze Ended Range Expansion -2.97%
    Gapped Up Strength -2.97%
    20 DMA Support Bullish -0.51%
    Bollinger Band Squeeze Range Contraction -0.51%
    Calm After Storm Range Contraction -0.51%
    Gapped Down Weakness -0.51%
    Older End-of-Day Signals for IMMP ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 20 hours ago
    20 DMA Support about 21 hours ago
    Down 5% about 21 hours ago
    1.5x Volume Pace about 22 hours ago
    Down 3% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IMMP Chart by TradingView
    Basic chart:

    Profile

    Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Autoimmune Disease Therapeutic Products

    Is IMMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
    Nov 14 Immutep stock jumps 11% on positive data for eftilagimod alpha
    Nov 14 Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
    Nov 14 Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
    Nov 14 Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting
    Nov 6 Immutep (ASX:IMM) shareholders have endured a 51% loss from investing in the stock three years ago
    Oct 29 Immutep Quarterly Activities Report Q1 FY25
    Oct 28 Immutep to Present New Phase IIb Data in PD-L1 Negative (CPS <1) Head and Neck Cancer at ESMO Immuno-Oncology 2024
    Oct 17 Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial
    Oct 10 Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
    See more IMMP news...

    Comments

    S

    SociableGnat503 over 1 year ago

    Any thoughts on what to expect here based on the chart? The volume looks quite low here. 

    0 Reply
    T

    TraderMike over 1 year ago

    looks range-bound to me

    0 Reply
    S

    SociableGnat503 over 1 year ago

    What does that mean, short term pain but long term gain? 

    0 Reply
    T

    TraderMike over 1 year ago

    It means it's stuck in a range -- going sideways between about 1.9 & 2.4

    0 Reply
    S

    SociableGnat503 about 1 year ago

    One can hope that it will ultimately pop given the potential and cash runway. 

    0 Reply
    T

    TraderMike about 1 year ago

    Hope is not a plan 😁

    0 Reply
    S

    SociableGnat503 about 1 year ago

    It's why I will never be rich....lol 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.335
    52 Week Low 1.58
    Average Volume 110,006
    200-Day Moving Average 2.34
    50-Day Moving Average 2.06
    20-Day Moving Average 1.92
    10-Day Moving Average 1.96
    Average True Range 0.12
    RSI (14) 48.98
    ADX 25.94
    +DI 21.52
    -DI 24.20
    Chandelier Exit (Long, 3 ATRs) 1.82
    Chandelier Exit (Short, 3 ATRs) 2.12
    Upper Bollinger Bands 2.08
    Lower Bollinger Band 1.76
    Percent B (%b) 0.64
    BandWidth 16.81
    MACD Line -0.01
    MACD Signal Line -0.04
    MACD Histogram 0.0241
    Fundamentals Value
    Market Cap 233.01 Million
    Num Shares 119 Million
    EPS -0.35
    Price-to-Earnings (P/E) Ratio -5.60
    Price-to-Sales 81.76
    Price-to-Book 3.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.14
    Resistance 3 (R3) 2.14 2.09 2.11
    Resistance 2 (R2) 2.09 2.04 2.09 2.10
    Resistance 1 (R1) 2.02 2.01 2.00 2.02 2.09
    Pivot Point 1.97 1.97 1.95 1.97 1.97
    Support 1 (S1) 1.90 1.92 1.88 1.90 1.83
    Support 2 (S2) 1.85 1.89 1.85 1.82
    Support 3 (S3) 1.78 1.85 1.81
    Support 4 (S4) 1.78